NCT01549509View on ClinicalTrials.gov

Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

October 31, 2009

Conditions
HIV Infections
Interventions
BIOLOGICAL

VRC-HIVADV014-00-VP Vaccine

All participants will receive one injection in their upper arm of 1 x 10\^10 particle units (PU)/mL of VRC-HIVADV014-00-VP at study entry.

Trial Locations (1)

Unknown

Makerere University Walter Reed Project (MUWRP), Kampala

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01549509 - Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda | Biotech Hunter | Biotech Hunter